Objectives: Despite different treatments and courses of illness, depressive symptoms appear similar in major depressive disorder (MDD) and bipolar I disorder (BP-I). This similarity of depressive symptoms suggests significant overlap in brain pathways underlying neurovegetative, mood, and cognitive symptoms of depression. These shared brain regions might be expected to exhibit similar activation in individuals with MDD and BP-I during functional magnetic resonance imaging (fMRI).

Methods: fMRI was used to compare regional brain activation in participants with BP-I (n = 25) and MDD (n = 25) during a depressive episode as well as 25 healthy comparison (HC) participants. During the scans, participants performed an attentional task that incorporated emotional pictures.

Results: During the viewing of emotional images, subjects with BP-I showed decreased activation in the middle occipital gyrus, lingual gyrus, and middle temporal gyrus compared to both subjects with MDD and HC participants. During attentional processing, participants with MDD had increased activation in the parahippocampus, parietal lobe, and postcentral gyrus. However, among these regions, only the postcentral gyrus also showed differences between MDD and HC participants.

Conclusions: No differences in cortico-limbic regions were found between participants with BP-I and MDD during depression. Instead, the major differences occurred in primary and secondary visual processing regions, with decreased activation in these regions in BP-I compared to major depression. These differences were driven by abnormal decreases in activation seen in the participants with BP-I. Posterior activation changes are a common finding in studies across mood states in participants with BP-I.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213254PMC
http://dx.doi.org/10.1111/bdi.12225DOI Listing

Publication Analysis

Top Keywords

participants bp-i
16
bipolar disorder
8
major depressive
8
depressive disorder
8
activation
8
brain activation
8
depressive symptoms
8
bp-i
8
participants
8
activation participants
8

Similar Publications

Exploring the phylogenetic framework and trait evolution of Impatiens through chloroplast genome analysis.

BMC Plant Biol

December 2024

College of Landscape Architecture and Horticulture Sciences, Southwest Research Center for Engineering Technology of Landscape Architecture (State Forestry and Grassland Administration), Yunnan Engineering Research Center for Functional Flower Resources and Industrialization, Research and Development Center of Landscape Plants and Horticulture Flowers, Southwest Forestry University, Kunming, Yunnan, 650224, China.

Background: The genus Impatiens, which includes both annual and perennial herbs, holds considerable ornamental, economic, and medicinal value. However, it posed significant challenges for taxonomic and systematic reconstruction. This was largely attributed to its high intraspecific diversity and low interspecific variation in morphological characteristics.

View Article and Find Full Text PDF

HLA-G high-expressor 3'UTR markers are linked to gastric cancer development and survival.

Cancer Immunol Immunother

November 2024

Departamento de Inmunología, Oftalmología y ORL, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Gastric cancer ranks fifth in both world prevalence and lethality, with a 5-year survival of less than 30%. HLA-G, a non-classical class I HLA gene, has emerged as a potential marker for cancer susceptibility and prognosis due to its immunomodulatory properties. Its level of expression is regulated by polymorphisms in the 3' untranslated region (3'UTR) polymorphisms, which form various combined haplotypes (UTR-1 to -9).

View Article and Find Full Text PDF
Article Synopsis
  • - The PUMAS project aims to address the lack of representation of African and Latin American populations in psychiatric genetics studies by analyzing genetic data from individuals with serious mental illness (SMI), including disorders like schizophrenia and bipolar disorder, using data from 89,320 participants across four different cohorts.
  • - The research involves harmonizing data from various clinical assessments to create standardized measures of mental health symptoms, which allows for more accurate genetic analyses across different diagnoses and symptoms.
  • - The findings show that schizophrenia and severe bipolar disorder are the most common diagnoses among participants, and a set of 19 key symptoms has been identified, which may be useful for cross-diagnosis genetic studies.
View Article and Find Full Text PDF
Article Synopsis
  • - Long-acting injectable antipsychotics (LAIs) are underutilized for treating bipolar disorder type I (BP-I) despite evidence showing their effectiveness, particularly in early stages of the disease.
  • - Psychiatrists identified barriers like provider attitudes, lack of awareness, and misconceptions about patient preferences as obstacles to LAI usage, highlighting a need for more communication between healthcare providers and patients.
  • - The review emphasizes the importance of stakeholder involvement and suggests that clinical studies could enhance understanding and acceptance of LAIs to improve treatment outcomes for BP-I patients.
View Article and Find Full Text PDF

Purpose: This study quantified the burdens of bipolar I disorder (BP-I) by examining patient characteristics, health-related quality of life (HRQoL), health care resource utilization (HCRU), and costs of patients with versus without BP-I. Additionally, these outcomes were assessed across BP-I severity levels.

Methods: A retrospective, cross-sectional analysis of the 2020 National Health and Wellness Survey was conducted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!